Medtronic Spinal and Biologics

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medtronic Spinal and Biologics sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).

26 total trials 1 currently recruiting 13 completed later-stage tilt top decile by trial count

Medtronic Spinal and Biologics: 26 sponsored US clinical trials, 1 recruiting.

Medtronic Spinal and Biologics sponsors 26 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 6 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Compression Fracture of Vertebral Body, with 1 trials.

Top-decile sponsor footprint

Medtronic Spinal and Biologics ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

13 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (56.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

26 total, page 1 of 1

RECRUITING NA

The Ailliance Post-Market Clinical Study

NCT05856370
ACTIVE NOT RECRUITING NA

Transforaminal Lumbar Interbody Fusion (TLIF)

NCT04073563
ACTIVE NOT RECRUITING NA

A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions

NCT03118505
TERMINATED NA

Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis

NCT04929678
COMPLETED

Diffusion MRI-1 Imaging Database

NCT03775694
TERMINATED NA

An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine

NCT03062657
COMPLETED

Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine

NCT02684045
TERMINATED

OLIF25™ /OLIF51™ Study

NCT02657421
COMPLETED Phase 2

A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT02077140
COMPLETED Phase 2

A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

NCT01917825
COMPLETED NA

Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs

NCT01871519
TERMINATED Phase 3

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

NCT01415908
TERMINATED Phase 3

Tibial Delayed Healing Pivotal Clinical Trial

NCT01016067
TERMINATED

Localized Alveolar Ridge Augmentation With Dental Implant

NCT00991965
TERMINATED

Localized Alveolar Ridge Augmentation With Space Maintenance Devices

NCT00991432
TERMINATED

Sinus Augmentation With Dental Implant

NCT00991393
TERMINATED Phase 3

DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion

NCT00627497
COMPLETED NA

INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial

NCT00485173
TERMINATED NA

Study of the Safety and Effectiveness of DIAM™ Spinal Stabilization System Versus Conservative Care

NCT00456378
COMPLETED NA

Study of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels

NCT00637156
COMPLETED NA

A-MAV™ Anterior Motion Segment Replacement

NCT00635934
COMPLETED Phase 3

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

NCT00667459
COMPLETED NA

Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF

NCT00437190
COMPLETED Phase 3

MAVERICK™ Total Disc Replacement- Pivotal Study

NCT00635843
COMPLETED NA

PRESTIGE® Cervical Disc Study

NCT00642876
COMPLETED Phase 3

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

NCT00707265

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 6

Therapeutic Areas

Compression Fracture of Vertebral Body 1
Spinal Diseases 1
Degenerative Disease of the Lumbosacral Spine 1
Multi-Level Degenerative Lumbosacral Spinal Conditions 1
Sciatica 1
Lumbosacral Radiculopathy 1
Osteoporosis 1
Spinal Tumor Case 1
Spinal Trauma 1
Spinal Fusion Failure 1

Where Medtronic Spinal and Biologics enrollment is open (later-stage tilt)

1 recruiting of 26 indexed (4% open); 13 completed (50%).

Phase mix: 6 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Compression Fracture of Vertebral Body (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medtronic Spinal and Biologics: open-pipeline peers nationwide

Peers matched on 26 registered trials and 4% open enrollment, not the therapeutic-area sidebar.

Medtronic Spinal and Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%5%10%15%20% Total trials Recruiting share Medtronic Spinal and BiologicsAbbott Diabetes CareAldeyra TherapeuticsCalifornia Polytechnic State University-San Luis ObispoDexComMaineHealthOklahoma State UniversityViiV HealthcareCelgene
Medtronic Spinal and Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medtronic Spinal and Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 26 trials (± recruiting share)

Sponsors near 4% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Medtronic Spinal and Biologics page

26 registered trials is a research-attention snapshot, not an endorsement of Medtronic Spinal and Biologics or any single study.

  • 1 of Medtronic Spinal and Biologics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Compression Fracture of Vertebral Body is the condition Medtronic Spinal and Biologics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Compression Fracture of Vertebral Body trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Medtronic Spinal and Biologics pipeline card: 26 registered trials from official public datasets.Report a data error.